Determination of HX0969w in rabbit whole blood by liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study

European Journal of Mass Spectrometry

Volumn 17, Issue 4, 2011, Pages 405-413

  Yin, Wang ^a,b   Wang, Yu ^a,b   Yang, Jun ^a   Kang, Yi ^a   Zhang, Wen Sheng ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

HX0969w; Liquid chromatography; Rabbit whole blood; Tandem mass spectrometry

Indexed keywords

BLOOD; CARBOXYLATION; ELECTROSPRAY IONIZATION; LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETRY; METABOLITES; PHARMACOKINETICS;

HX0969W; INTRAVENOUS ADMINISTRATION; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LOWER LIMIT OF QUANTIFICATIONS; PHARMACOKINETIC STUDIES; PROTEIN PRECIPITATION; TANDEM MASS SPECTROMETRY; WHOLE BLOOD;

HIGH PRESSURE LIQUID CHROMATOGRAPHY;

EID: 80054764465     PISSN: 14690667     EISSN: None     Source Type: Journal    
DOI: 10.1255/ejms.1138     Document Type: Article

References (13)

1. H.M. Bryson, B.R. Fulton and D. Faulds, "Propofol. An update of its use in anaesthesia and conscious sedation", Drugs 50, 513 (1995).
2. J.B. Glen and S.C. Hunter,"Pharmacology of an emulsion formulation of ICI 35 868", Br. J. Anaesth. 56, 617 (1984). doi: 10.1093/bja/56.6.617
3. M.T. Baker and M. Naguib, "Propofol: the challenges of formulation", Anesthesiology 103, 860 (2005).
4. K.P. Garnock-Jones and L.J. Scott, "Fospropofol", Drugs 70, 469 (2010). doi: 10.2165/11204450-000000000-00000
5. P. Vayer, P. Mandel and M. Maitre, "Gamma-hydroxybutyrate, a possible neurotransmitter", Life Sci. 41, 1547 (1987).
6. J. Fechner, H. Ihmsen, C. Schiessl, C. Jeleazcov, J.J. Vornov, H. Schwilden and J. Schuttler, "Sedation with GPI 15715, a water-soluble prodrug of propofol, using target-controlled infusion in volunteers", Anesth. Analg. 100, 701 (2005). doi: 10.1213/01.ANE.0000144772.13372.F4 (Pubitemid 40300064)
7. US FDA, Guidance for Industry: Bioanalytical Method Validation. US Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research, Silver Spring, Maryland, USA (2001).
8. M.M.R.F. Struys, J. Fechner, J. Schüttler and H. Schwilden, "Erroneously published fospropofol pharmacokinetic-pharmacodynamic data and retraction of the affected publications", Anesthesiology 112, 1056 (2010). doi: 10.1097/ALN.0b013e3181d536df
9. L. Bajpai, M. Varshney, C.N. Seubert and D.M. Dennis, "A new method for the quantitation of propofol in human plasma: efficient solid-phase extraction and liquid chromatography/APCI-triple quadrupole mass spectrometry detection", J. Chromatogr. B. 810, 291 (2004). doi: 10.1016/j.jchromb.2004. 08.023 (Pubitemid 39243317)
10. L. Bajpai, M. Varshney, C.N. Seubert, S.M. Stevens Jr, J.V. Johnson, R.A. Yost and D.M. Dennis, "Mass spectral fragmentation of the intravenous anesthetic propofol and structurally related phenols", J. Am. Soc. Mass. Spectrom. 16, 814 (2005). doi: 10.1016/j.jasms.2005.02.009 (Pubitemid 40725157)
11. F. Beaudry, S.A. Guénette, A. Winterborn, J.-F. Marier and P. Vachon, "Development of a rapid and sensitive LC-ESI/MS/MS assay for the quantification of propofol using a simple off-line dansyl chloride derivatization reaction to enhance signal intensity", J. Pharm. Biomed. Anal. 39, 411 (2005). doi: 10.1016/j.jpba.2005.04.041 (Pubitemid 41196043)
12. X. Cussonneau, E. De Smet, K. Lantsoght, J.-P. Salvi, M. Bolon-Larger and R. Boulieu, "A rapid and simple HPLCmethod for the analysis of propofol in biological fluids", J. Pharm. Biomed. Anal. 44, 680 (2007). doi: 10.1016/j.jpba.2006.10.020 (Pubitemid 47039193)
13. G. Shi, "Application of co-eluting structural analog internal standards for expanded linear dynamic range in liquid chromatography/ electrospray mass spectrometry", Rapid Commun. Mass Spectrom. 17, 202 (2003). doi: 10.1002/rcm.897 (Pubitemid 36164166)